NEKTAR THERAPEUTICS
NKTR
DELAYED 1 MONTH
4 insider filings · Latest: Jul 24, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 19, 2026 | May 21 10:26 PM | Jonathan ZalevskyChief R&D Officer | Sale | 199 | $65.51 | $13.0K | 20,975(D) | View → |
| May 19, 2026 | May 21 10:26 PM | Howard W RobinDirector, President & CEO | Sale | 444 | $65.51 | $29.1K | 75,045(D) | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jul 24, 2026 | Jul 24 10:35 PM | Jonathan ZalevskyChief R&D Officer | Grant/Award | 16,500 | $15.15 | 16,500(D) | View → |
| Jul 24, 2026 | Jul 24 10:34 PM | Howard W RobinDirector, President & CEO | Grant/Award | 57,200 | $15.15 | 57,200(D) | View → |